JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

Search

iRhythm Technologies Inc

Fermé

SecteurSoins de santé

160.08 -2.83

Résumé

Variation du prix de l'action

24h

Actuel

Min

157.68

Max

164.8

Chiffres clés

By Trading Economics

Revenu

16M

-14M

Ventes

28M

187M

BPA

-0.95

Marge bénéficiaire

-7.616

Employés

2,000

EBITDA

14M

-19M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+6.32% upside

Dividendes

By Dow Jones

Prochains Résultats

29 oct. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

923M

5.3B

Ouverture précédente

162.91

Clôture précédente

160.08

Sentiment de l'Actualité

By Acuity

35%

65%

121 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

iRhythm Technologies Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 août 2025, 23:11 UTC

Résultats

Australia's REA Hikes Dividend as Annual Profit Rises 23% -- Update

5 août 2025, 22:45 UTC

Résultats

Australia's REA Hikes Dividend as Annual Profit Rises 23%

5 août 2025, 22:39 UTC

Résultats

Great-West Lifeco Logs Lower 2Q Profit

5 août 2025, 21:32 UTC

Résultats

Coupang Posts Higher 2Q Sales Due to Customer Growth

6 août 2025, 00:00 UTC

Acquisitions, Fusions, Rachats

NFL to Take 10% Stake in Disney's ESPN -- WSJ

6 août 2025, 00:00 UTC

Acquisitions, Fusions, Rachats

The NFL Is Taking a 10% Stake in Disney's ESPN -- WSJ

6 août 2025, 00:00 UTC

Acquisitions, Fusions, Rachats

Disney to Take Control of NFL Network as Part of Agreement -- WSJ

6 août 2025, 00:00 UTC

Acquisitions, Fusions, Rachats

Disney, NFL Strike Wide-Reaching Media-Asset Deal -- WSJ

5 août 2025, 23:48 UTC

Market Talk

Nikkei May Decline Amid U.S. Economic Uncertainty -- Market Talk

5 août 2025, 23:40 UTC

Market Talk

Gold Edges Higher, Supported by Fed Rate-Cut Hopes -- Market Talk

5 août 2025, 23:19 UTC

Market Talk

Lindian Deal With Iluka Demonstrates Kangankunde Project Appeal -- Market Talk

5 août 2025, 23:03 UTC

Market Talk
Résultats

Advanced Micro Devices' Data-Center Story Seen as Promising -- Market Talk

5 août 2025, 22:22 UTC

Résultats

REA: Expectation of More Interest-Rate Cuts Likely to Support Buyer Demand>REA.AU

5 août 2025, 22:21 UTC

Résultats

REA Expects FY26 Listing Volumes Broadly Flat on FY25>REA.AU

5 août 2025, 22:20 UTC

Résultats

REA Expects September-Quarter Listings to Be Down on Year>REA.AU

5 août 2025, 22:18 UTC

Résultats

REA July 2025 New Residential Listings Down 8% on Year>REA.AU

5 août 2025, 22:17 UTC

Résultats

REA FY25 Australian Residential Listings Up 1% on Year>REA.AU

5 août 2025, 22:17 UTC

Résultats

REA FY25 India Revenue A$129M Vs. A$103M>REA.AU

5 août 2025, 22:16 UTC

Résultats

REA FY25 Core Australia Revenue A$1.54B Vs. A$1.35B>REA.AU

5 août 2025, 22:16 UTC

Résultats

REA FY25 Core Operations Net Profit A$564.4M Vs. A$460.5M>REA.AU

5 août 2025, 22:15 UTC

Résultats

REA Group FY25 Ebitda A$969.2M Vs. A$824.8M>REA.AU

5 août 2025, 22:13 UTC

Résultats

REA Group Raises Dividend to A$1.38 Vs. A$1.02 >REA.AU

5 août 2025, 22:13 UTC

Résultats

REA Group FY25 Rev A$1.67B Vs. A$1.45B >REA.AU

5 août 2025, 22:12 UTC

Résultats

REA FY25 Core Operations Net Profit A$564.4M Vs, A$460.5M>REA.AU

5 août 2025, 22:12 UTC

Résultats

REA Group FY25 Net A$677.9M Vs. Net A$302.8M >REA.AU

5 août 2025, 21:58 UTC

Résultats

Novo Nordisk's Earnings Come After a Dramatic Guidance Cut. What to Look for Now. -- Barrons.com

5 août 2025, 21:30 UTC

Résultats

AMD Gives a Strong Outlook. Why the Stock Is Falling. -- Barrons.com

5 août 2025, 21:26 UTC

Résultats

AMD CEO Expects Embedded Segment to Return to Sequential Growth in Back Half of 2025

5 août 2025, 21:23 UTC

Résultats

AMD CEO Sees Strong Customer Interest in MI400 Series for Large-Scale Deployments

5 août 2025, 21:17 UTC

Résultats

AMD Expects Steep Production Ramp for MI350 Series in Back Half of Year, CEO Says

Comparaison

Variation de prix

iRhythm Technologies Inc prévision

Objectif de Prix

By TipRanks

6.32% hausse

Prévisions sur 12 Mois

Moyen 175.4 USD  6.32%

Haut 190 USD

Bas 147 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

11 ratings

11

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

104.78 / 137.91Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

121 / 374Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.